category,subcategory,ID,Description,GeneRatio,BgRatio,RichFactor,FoldEnrichment,zScore,pvalue,p.adjust,qvalue,geneID,Count
Environmental Information Processing,Signaling molecules and interaction,hsa04060,Cytokine-cytokine receptor interaction,31/225,127/2914,0.2440944881889764,3.161294838145232,7.203001290945585,2.334340434609216e-9,6.302719173444883e-7,5.35669699731378e-7,TNFRSF12A/NGFR/TNFRSF1A/IL4R/CXCL2/OSM/CSF2RB/IL7/TNFRSF10A/CSF3/CCL2/IL1R1/IL1RL1/IL18RAP/TNFRSF10B/TNFSF10/IL1B/LIF/IL15RA/IL6/OSMR/IFNA5/TNFRSF13C/CXCR1/CCR1/CX3CR1/IL12A/TNFRSF10D/TNFRSF10C/CXCR2/RELL1,31
Environmental Information Processing,Signaling molecules and interaction,hsa04061,Viral protein interaction with cytokine and cytokine receptor,14/225,37/2914,0.3783783783783784,4.900420420420421,6.905711849428412,2.2161893577677228e-7,2.9918556329864257e-5,2.542785684175598e-5,TNFRSF1A/CXCL2/TNFRSF10A/CCL2/IL18RAP/TNFRSF10B/TNFSF10/IL6/CXCR1/CCR1/CX3CR1/TNFRSF10D/TNFRSF10C/CXCR2,14
Environmental Information Processing,Signal transduction,hsa04630,JAK-STAT signaling pathway,16/225,59/2914,0.2711864406779661,3.512165725047081,5.638159216210534,5.132870316407508e-6,4.6195832847667576e-4,3.9261955402696035e-4,IL4R/OSM/CSF2RB/IL7/CSF3/CISH/CDKN1A/LIF/IL15RA/IL6/MYC/PIM1/OSMR/IFNA5/IL12A/SOCS3,16
Human Diseases,Infectious disease: parasitic,hsa05144,Malaria,11/225,32/2914,0.34375,4.451944444444444,5.678817326738819,1.3773935312008043e-5,9.297406335605429e-4,7.901889205309877e-4,SELE/ICAM1/CSF3/CCL2/IL1B/IL6/TLR2/THBS1/IL12A/CR1/ACKR1,11
Human Diseases,Endocrine and metabolic disease,hsa04933,AGE-RAGE signaling pathway in diabetic complications,14/225,52/2914,0.2692307692307692,3.486837606837607,5.233357264766355,2.239423310044701e-5,0.0012092885874241386,0.0010277774349257787,SELE/EDN1/ICAM1/CCL2/VEGFA/F3/EGR1/IL1B/COL4A2/IL6/PIM1/NOS3/THBD/COL4A1,14
Environmental Information Processing,Signal transduction,hsa04064,NF-kappa B signaling pathway,13/225,47/2914,0.2765957446808511,3.582222222222222,5.1617242157061405,3.239924545394306e-5,0.0014579660454274376,0.0012391290366595767,TNFRSF1A/CXCL2/ICAM1/BLNK/GADD45B/IL1R1/GADD45A/IL1B/BCL2A1/LY96/TNFRSF13C/CD14/CARD11,13
Organismal Systems,Immune system,hsa04640,Hematopoietic cell lineage,13/225,49/2914,0.2653061224489796,3.436009070294785,4.97371307724544,5.258158610015846e-5,0.002028146892434683,0.0017237271834337664,IL4R/IL7/CSF3/IL1R1/CR2/IL1B/IL6/FCGR1A/ITGA5/CD14/CR1/CD8B2/ITGB3,13
Organismal Systems,Immune system,hsa04610,Complement and coagulation cascades,11/225,40/2914,0.275,3.5615555555555556,4.717984322310659,1.41537715036231e-4,0.004776897882472797,0.0040598976155129425,PLAUR/CR2/F3/F10/MASP1/F2RL3/BDKRB2/THBD/SERPINA1/C5AR1/CR1,11
Environmental Information Processing,Signal transduction,hsa04151,PI3K-Akt signaling pathway,27/225,171/2914,0.15789473684210525,2.0449122807017543,4.073156388057092,1.903133221104879e-4,0.005374474948026989,0.004567779877855296,NGFR/IL4R/FGF20/ANGPT2/OSM/IL7/CSF3/VEGFA/SPP1/NR4A1/CDK2/CDKN1A/COL4A2/IL6/MYC/TLR2/THBS1/FGF2/EPHA2/OSMR/IFNA5/CREB3L1/ITGA5/NOS3/EFNA1/COL4A1/ITGB3,27
Human Diseases,Infectious disease: bacterial,hsa05150,Staphylococcus aureus infection,10/225,35/2914,0.2857142857142857,3.7003174603174602,4.648299625920756,2.0234213291669276e-4,0.005374474948026989,0.004567779877855296,ICAM1/SELPLG/MASP1/FCGR2A/FCGR1A/FCGR3B/FPR2/FPR1/C5AR1/FCGR3A,10
Environmental Information Processing,Signal transduction,hsa04668,TNF signaling pathway,14/225,63/2914,0.2222222222222222,2.8780246913580245,4.358520210869228,2.189600904751736e-4,0.005374474948026989,0.004567779877855296,SELE/TNFRSF1A/BCL3/EDN1/CXCL2/ICAM1/CCL2/IRF1/IL1B/LIF/IL6/CREB3L1/NOD2/SOCS3,14
Cellular Processes,Transport and catabolism,hsa04145,Phagosome,14/225,66/2914,0.21212121212121213,2.7472053872053874,4.1525228952438225,3.6751757169054466e-4,0.007633057258188236,0.00648735470676427,MSR1/CD209/NCF2/TLR2/THBS1/FCGR2A/FCGR1A/ITGA5/FCGR3B/CD14/TUBB6/SFTPA2/FCGR3A/ITGB3,14
Human Diseases,Cardiovascular disease,hsa05418,Fluid shear stress and atherosclerosis,14/225,66/2914,0.21212121212121213,2.7472053872053874,4.1525228952438225,3.6751757169054466e-4,0.007633057258188236,0.00648735470676427,SELE/TNFRSF1A/EDN1/ICAM1/CCL2/VEGFA/IL1R1/NCF2/IL1B/RAC2/NOS3/THBD/CDH5/ITGB3,14
Human Diseases,Cardiovascular disease,hsa05417,Lipid and atherosclerosis,17/225,93/2914,0.1827956989247312,2.3674074074074074,3.8761802076653042,5.71302766589855e-4,0.011017981927090059,0.009364210760645742,SELE/TNFRSF1A/CXCL2/ICAM1/TNFRSF10A/CCL2/NCF2/TNFRSF10B/TNFSF10/IL1B/IL6/TLR2/IFNA5/LY96/NOS3/IL12A/CD14,17
Organismal Systems,Immune system,hsa04613,Neutrophil extracellular trap formation,16/225,88/2914,0.18181818181818182,2.354747474747475,3.732327182146456,8.825412476559273e-4,0.015469494381458731,0.013147562476249527,TLR8/SELPLG/NCF2/RAC2/SIGLEC9/TLR2/FCGR2A/FCGR1A/FCGR3B/FPR2/FPR1/CASP4/C5AR1/CR1/FCGR3A/ITGB3,16
Human Diseases,Infectious disease: bacterial,hsa05152,Tuberculosis,15/225,80/2914,0.1875,2.4283333333333332,3.746629448376503,9.167107781605174e-4,0.015469494381458731,0.013147562476249527,TNFRSF1A/CD209/IL1B/IL6/TLR2/FCGR2A/IFNA5/FCGR1A/FCER1G/FCGR3B/NOD2/IL12A/CD14/CR1/FCGR3A,15
Organismal Systems,Development and regeneration,hsa04380,Osteoclast differentiation,13/225,65/2914,0.2,2.5902222222222226,3.7500268052241967,0.0010761811751067631,0.01709228925169565,0.01452677994880956,TNFRSF1A/BLNK/IL1R1/NCF2/IL1B/FOSB/FCGR2A/FCGR1A/FCGR3B/FOSL1/SOCS3/FCGR3A/ITGB3,13
Organismal Systems,Immune system,hsa04657,IL-17 signaling pathway,9/225,37/2914,0.24324324324324326,3.1502702702702705,3.807063158406517,0.001522803342143298,0.022842050132149468,0.019413516291651403,CXCL2/CSF3/CCL2/IL1B/FOSB/IL6/S100A8/S100A9/FOSL1,9
Human Diseases,Infectious disease: viral,hsa05166,Human T-cell leukemia virus 1 infection,15/225,85/2914,0.17647058823529413,2.2854901960784315,3.478787157893307,0.001750931335595147,0.024881655821615247,0.021146982335719784,TNFRSF1A/ICAM1/IL1R1/EGR1/EGR2/CDK2/CDKN1A/ZFP36/IL15RA/IL6/MYC/CCNB2/CREB3L1/TNFRSF13C/FOSL1,15
Cellular Processes,Cell growth and death,hsa04115,p53 signaling pathway,8/225,31/2914,0.25806451612903225,3.3422222222222224,3.7918637438106826,0.0018502536085034148,0.0249784237147961,0.021229225613354972,GADD45B/TNFRSF10A/GADD45A/TNFRSF10B/CDK2/CDKN1A/THBS1/CCNB2,8
Human Diseases,Immune disease,hsa05321,Inflammatory bowel disease,7/225,25/2914,0.28,3.6263111111111113,3.8142442896383084,0.0021456107918676826,0.027586424466870207,0.023445772061511518,IL4R/IL18RAP/IL1B/IL6/TLR2/NOD2/IL12A,7
Human Diseases,Infectious disease: viral,hsa05164,Influenza A,11/225,56/2914,0.19642857142857142,2.543968253968254,3.3741731714046304,0.003015017383615107,0.03700248607163995,0.03144850668077002,TNFRSF1A/ICAM1/TNFRSF10A/CCL2/TNFRSF10B/TNFSF10/IL1B/IL6/IFNA5/IL12A/SOCS3,11
Human Diseases,Infectious disease: parasitic,hsa05140,Leishmaniasis,9/225,41/2914,0.21951219512195122,2.8429268292682925,3.4371485963093233,0.0032660452038244755,0.037467328807353956,0.031843577699817396,NCF2/IL1B/TLR2/FCGR2A/FCGR1A/FCGR3B/IL12A/CR1/FCGR3A,9
Human Diseases,Infectious disease: viral,hsa05168,Herpes simplex virus 1 infection,10/225,49/2914,0.20408163265306123,2.643083900226758,3.354760859154081,0.0034596983184389373,0.037467328807353956,0.031843577699817396,TNFRSF1A/CCL2/IL1B/IL6/TLR2/IFNA5/ITGA5/IL12A/SOCS3/ITGB3,10
Human Diseases,Infectious disease: bacterial,hsa05134,Legionellosis,7/225,27/2914,0.25925925925925924,3.3576954732510287,3.5596909958896985,0.003469197111792033,0.037467328807353956,0.031843577699817396,CXCL2/IL1B/IL6/TLR2/IL12A/CD14/CR1,7
Organismal Systems,Immune system,hsa04621,NOD-like receptor signaling pathway,13/225,78/2914,0.16666666666666666,2.1585185185185183,2.9995994726522666,0.00585572328619475,0.06080943412586856,0.05168209216155691,CXCL2/NAMPT/CCL2/GBP1/IL1B/IL6/IFNA5/GBP5/GBP2/IFI16/NOD2/CASP4/CASP12,13
Organismal Systems,Immune system,hsa04620,Toll-like receptor signaling pathway,9/225,45/2914,0.2,2.5902222222222226,3.109316282642271,0.006296954840003373,0.06296954840003373,0.05351797875714368,TLR8/SPP1/IL1B/IL6/TLR2/IFNA5/LY96/IL12A/CD14,9
Human Diseases,Infectious disease: viral,hsa05167,Kaposi sarcoma-associated herpesvirus infection,13/225,79/2914,0.16455696202531644,2.1311954992967648,2.948090306662933,0.006539869655385725,0.06306302881979092,0.053597428002785275,TNFRSF1A/CXCL2/ICAM1/ANGPT2/HCK/VEGFA/CDKN1A/ZFP36/IL6/MYC/FGF2/IFNA5/CCR1,13
Human Diseases,Infectious disease: parasitic,hsa05146,Amoebiasis,9/225,48/2914,0.1875,2.4283333333333332,2.885879528572465,0.009727560558280165,0.09056694312881532,0.07697307447205357,CXCL2/IL1R1/IL1B/COL4A2/IL6/TLR2/IL12A/CD14/COL4A1,9
Human Diseases,Cancer: overview,hsa05202,Transcriptional misregulation in cancer,12/225,75/2914,0.16,2.0721777777777777,2.720701132404646,0.011063855909161409,0.09700690263890298,0.08244641237926258,NGFR/GADD45B/GADD45A/NR4A3/CDKN1A/IL6/MYC/BCL2A1/FCGR1A/HHEX/RUNX1/CD14,12
Environmental Information Processing,Signal transduction,hsa04066,HIF-1 signaling pathway,9/225,49/2914,0.1836734693877551,2.3787755102040817,2.8151101197902944,0.011137829562244416,0.09700690263890298,0.08244641237926258,EDN1/ANGPT2/TIMP1/VEGFA/CDKN1A/IL6/PDK1/HK2/NOS3,9
Human Diseases,Infectious disease: parasitic,hsa05143,African trypanosomiasis,5/225,19/2914,0.2631578947368421,3.4081871345029238,3.045852362877401,0.012441674028698838,0.10497662461714645,0.08921989928474826,SELE/ICAM1/IL1B/IL6/IL12A,5
Human Diseases,Infectious disease: viral,hsa05163,Human cytomegalovirus infection,14/225,95/2914,0.14736842105263157,1.9085847953216373,2.6040290799805117,0.012865358470247275,0.10499906245432332,0.0892389692594249,TNFRSF1A/CCL2/VEGFA/IL1R1/CDKN1A/IL1B/RAC2/IL6/MYC/IFNA5/CREB3L1/CCR1/CXCR2/ITGB3,14
Human Diseases,Infectious disease: bacterial,hsa05133,Pertussis,8/225,42/2914,0.19047619047619047,2.4668783068783067,2.769444164685097,0.013222104160914789,0.10499906245432332,0.0892389692594249,IRF1/IL1B/IL6/LY96/ITGA5/IL12A/CD14/SFTPA2,8
Human Diseases,Cancer: specific types,hsa05221,Acute myeloid leukemia,6/225,27/2914,0.2222222222222222,2.8780246913580245,2.8354754291772375,0.014789733026796268,0.11409222620671407,0.09696727217568682,MYC/PIM1/BCL2A1/FCGR1A/RUNX1/CD14,6
Human Diseases,Infectious disease: bacterial,hsa05132,Salmonella infection,14/225,98/2914,0.14285714285714285,1.8501587301587301,2.476069506635772,0.0166825020234082,0.1251187651755615,0.10633875558780669,TNFRSF1A/TNFRSF10A/TNFRSF10B/TNFSF10/IL1B/IL6/MYC/TLR2/LY96/CD14/TUBB6/ANXA2/CASP4/CYFIP1,14
Human Diseases,Cancer: specific types,hsa05222,Small cell lung cancer,7/225,36/2914,0.19444444444444445,2.5182716049382714,2.6510714069665924,0.01797647952508935,0.12830994784716576,0.10905094982722081,GADD45B/GADD45A/CDK2/CDKN1A/COL4A2/MYC/COL4A1,7
Human Diseases,Infectious disease: bacterial,hsa05130,Pathogenic Escherichia coli infection,12/225,80/2914,0.15,1.9426666666666665,2.4726880000020417,0.018095106670192856,0.12830994784716576,0.10905094982722081,TNFRSF1A/TNFRSF10A/IL1R1/TNFRSF10B/TNFSF10/IL1B/IL6/MYO1G/FCGR2A/TUBB6/CASP4/CYFIP1,12
Human Diseases,Infectious disease: viral,hsa05169,Epstein-Barr virus infection,11/225,71/2914,0.15492957746478872,2.0065101721439746,2.4832761252385827,0.0185336591334795,0.12830994784716576,0.10905094982722081,ICAM1/BLNK/GADD45B/GADD45A/CR2/CDK2/CDKN1A/IL6/MYC/TLR2/IFNA5,11
Organismal Systems,Immune system,hsa04625,C-type lectin receptor signaling pathway,8/225,46/2914,0.17391304347826086,2.252367149758454,2.4762079291071397,0.022390863093004393,0.14794624020088412,0.12573988445923096,BCL3/CD209/EGR2/IRF1/IL1B/IL6/FCER1G/IL12A,8
Environmental Information Processing,Signal transduction,hsa04068,FoxO signaling pathway,9/225,55/2914,0.16363636363636364,2.119272727272727,2.4236856359097354,0.023013859586804197,0.14794624020088412,0.12573988445923096,GADD45B/GADD45A/TNFSF10/CDK2/CDKN1A/IL6/PLK4/CCNB2/DEPP1,9
Cellular Processes,Cell growth and death,hsa04210,Apoptosis,9/225,55/2914,0.16363636363636364,2.119272727272727,2.4236856359097354,0.023013859586804197,0.14794624020088412,0.12573988445923096,TNFRSF1A/GADD45B/CSF2RB/TNFRSF10A/GADD45A/TNFRSF10B/TNFSF10/BCL2A1/CASP12,9
Human Diseases,Cancer: specific types,hsa05216,Thyroid cancer,4/225,15/2914,0.26666666666666666,3.453629629629629,2.755475980200917,0.02396829022606293,0.15049856653574395,0.12790911307911185,GADD45B/GADD45A/CDKN1A/MYC,4
Organismal Systems,Immune system,hsa04650,Natural killer cell mediated cytotoxicity,9/225,56/2914,0.16071428571428573,2.0814285714285714,2.3633434580836585,0.02564105724324881,0.15479717325643796,0.1315625098241851,ICAM1/TNFRSF10A/TNFRSF10B/TNFSF10/RAC2/IFNA5/FCER1G/FCGR3B/FCGR3A,9
Human Diseases,Infectious disease: viral,hsa05171,Coronavirus disease - COVID-19,12/225,84/2914,0.14285714285714285,1.8501587301587301,2.2867176528411273,0.025799528876072994,0.15479717325643796,0.1315625098241851,TNFRSF1A/TLR8/CSF3/CCL2/IL1B/MASP1/IL6/TLR2/FCGR2A/IFNA5/IL12A/C5AR1,12
Human Diseases,Endocrine and metabolic disease,hsa04931,Insulin resistance,7/225,39/2914,0.1794871794871795,2.3245584045584042,2.4085218575211136,0.02720183790277099,0.15966296160322102,0.13569795567057383,TNFRSF1A/PYGL/IL6/CREB3L1/NOS3/PPP1R3B/SOCS3,7
Organismal Systems,Digestive system,hsa04978,Mineral absorption,5/225,25/2914,0.2,2.5902222222222226,2.309511620579075,0.03894724649763354,0.22373950115661823,0.19015676901420187,MT2A/SLC26A9/MT1X/MT1A/MT1M,5
Human Diseases,Cancer: overview,hsa05206,MicroRNAs in cancer,11/225,81/2914,0.13580246913580246,1.7587928669410149,2.0031273563361305,0.044463067486861255,0.24683044816758942,0.20978182339389664,VEGFA/CDKN1A/MYC/PIM1/THBS1/CYP1B1/ITGA5/EFNA1/MIR494/MIR9-1/ITGB3,11
Human Diseases,Cancer: specific types,hsa05219,Bladder cancer,4/225,18/2914,0.2222222222222222,2.8780246913580245,2.3115557484682525,0.04479515540819215,0.24683044816758942,0.20978182339389664,VEGFA/CDKN1A/MYC/THBS1,4
Human Diseases,Endocrine and metabolic disease,hsa04936,Alcoholic liver disease,9/225,62/2914,0.14516129032258066,1.8800000000000003,2.0256754119097895,0.04597144177860196,0.24824578560445063,0.21098472226811005,TNFRSF1A/CXCL2/IL1B/IL6/IFNA5/LY96/IL12A/CD14/C5AR1,9
Organismal Systems,Immune system,hsa04666,Fc gamma R-mediated phagocytosis,7/225,44/2914,0.1590909090909091,2.0604040404040402,2.049853689687927,0.0489053060106122,0.25637710994403584,0.2178955554300188,HCK/RAC2/FCGR2A/FCGR1A/FCGR3B/LIMK2/FCGR3A,7
Environmental Information Processing,Signal transduction,hsa04010,MAPK signaling pathway,18/225,155/2914,0.11612903225806452,1.5040000000000002,1.8650334934476958,0.049376332285518014,0.25637710994403584,0.2178955554300188,NGFR/TNFRSF1A/FGF20/ANGPT2/GADD45B/VEGFA/IL1R1/GADD45A/DUSP4/NR4A1/IL1B/RAC2/MYC/FGF2/EPHA2/DUSP2/EFNA1/CD14,18
Human Diseases,Cancer: specific types,hsa05220,Chronic myeloid leukemia,5/225,27/2914,0.18518518518518517,2.3983539094650204,2.111259862464776,0.05223170387956232,0.2660860386317326,0.22614719852521523,GADD45B/GADD45A/CDKN1A/MYC/RUNX1,5
Human Diseases,Immune disease,hsa05323,Rheumatoid arthritis,7/225,45/2914,0.15555555555555556,2.014617283950617,1.9838523179668377,0.05427249503123786,0.2681867926598202,0.22793263469723513,CXCL2/ICAM1/CCL2/VEGFA/IL1B/IL6/TLR2,7
Human Diseases,Infectious disease: viral,hsa05161,Hepatitis B,9/225,64/2914,0.140625,1.82125,1.9213613040069077,0.05463064294922264,0.2681867926598202,0.22793263469723513,EGR2/CDK2/CDKN1A/IL6/MYC/TLR2/IFNA5/CREB3L1/CASP12,9
Human Diseases,Cancer: overview,hsa05200,Pathways in cancer,26/225,249/2914,0.10441767068273092,1.3523248549754574,1.681358984655109,0.06388838772226708,0.3045362855499597,0.25882616081828935,WNT8A/IL4R/EDN1/FGF20/GADD45B/CSF2RB/IL7/VEGFA/GADD45A/CDK2/CDKN1A/F2RL3/RAC2/DLL4/IL15RA/COL4A2/IL6/MYC/PIM1/FGF2/IFNA5/RUNX1/BDKRB2/IL12A/COL4A1/WNT7B,26
Human Diseases,Cancer: specific types,hsa05226,Gastric cancer,9/225,66/2914,0.13636363636363635,1.7660606060606059,1.820669870357424,0.0642909936161026,0.3045362855499597,0.25882616081828935,WNT8A/FGF20/GADD45B/GADD45A/CDK2/CDKN1A/MYC/FGF2/WNT7B,9
Environmental Information Processing,Signal transduction,hsa04015,Rap1 signaling pathway,13/225,107/2914,0.12149532710280374,1.5734994807892004,1.7481142451716885,0.06542277770193264,0.30455430999175537,0.25884147983704753,NGFR/FGF20/ANGPT2/VEGFA/ARAP3/F2RL3/RAC2/THBS1/FGF2/EPHA2/EFNA1/FPR1/ITGB3,13
Genetic Information Processing,Information processing in viruses,hsa03265,"Virion - Ebolavirus, Lyssavirus and Morbillivirus",2/225,6/2914,0.3333333333333333,4.317037037037037,2.352311572258158,0.07237251737346759,0.33119626594637713,0.281484545716609,NGFR/CD209,2
Cellular Processes,Cell growth and death,hsa04217,Necroptosis,8/225,58/2914,0.13793103448275862,1.7863601532567048,1.749534432102125,0.07451939169841838,0.3353372626428827,0.28500398930272297,TNFRSF1A/PYGL/TNFRSF10A/TNFRSF10B/TNFSF10/IL1B/IFNA5/SPATA2L,8
Human Diseases,Infectious disease: parasitic,hsa05142,Chagas disease,7/225,49/2914,0.14285714285714285,1.8501587301587301,1.7358086410627216,0.07931613472429948,0.35107141599280095,0.29837648610694195,TNFRSF1A/CCL2/IL1B/IL6/TLR2/BDKRB2/IL12A,7
Human Diseases,Cancer: specific types,hsa05212,Pancreatic cancer,5/225,31/2914,0.16129032258064516,2.088888888888889,1.762820905566636,0.08579348615400656,0.3676863692314567,0.3124975769686455,GADD45B/VEGFA/GADD45A/CDKN1A/RAC2,5
Human Diseases,Cancer: specific types,hsa05218,Melanoma,5/225,31/2914,0.16129032258064516,2.088888888888889,1.762820905566636,0.08579348615400656,0.3676863692314567,0.3124975769686455,FGF20/GADD45B/GADD45A/CDKN1A/FGF2,5
Human Diseases,Cancer: overview,hsa05205,Proteoglycans in cancer,11/225,91/2914,0.12087912087912088,1.5655189255189255,1.5851796955188824,0.08843823454183923,0.37309880197338424,0.3170976172717262,PLAUR/WNT8A/VEGFA/CDKN1A/MYC/TLR2/THBS1/FGF2/ITGA5/WNT7B/ITGB3,11
Human Diseases,Infectious disease: viral,hsa05162,Measles,7/225,52/2914,0.1346153846153846,1.7434188034188034,1.5644673318991533,0.1018629979030037,0.4177936783012574,0.3550839059246555,CD209/CDK2/IL1B/IL6/TLR2/IFNA5/IL12A,7
Metabolism,Carbohydrate metabolism,hsa00500,Starch and sucrose metabolism,3/225,15/2914,0.2,2.5902222222222226,1.7858519002219928,0.10367472757846018,0.4177936783012574,0.3550839059246555,SI/PYGL/HK2,3
Human Diseases,Immune disease,hsa05340,Primary immunodeficiency,3/225,15/2914,0.2,2.5902222222222226,1.7858519002219928,0.10367472757846018,0.4177936783012574,0.3550839059246555,BLNK/TNFRSF13C/CD8B2,3
Human Diseases,Cancer: overview,hsa05230,Central carbon metabolism in cancer,5/225,33/2914,0.15151515151515152,1.9622895622895622,1.607893265426749,0.10597020014503872,0.4207640299876537,0.3576084153501307,SLC1A5/MYC/SLC16A3/PDK1/HK2,5
Cellular Processes,Cell growth and death,hsa04218,Cellular senescence,7/225,53/2914,0.1320754716981132,1.710524109014675,1.5098156573368269,0.11008222480332294,0.4307565318390898,0.3661010679957956,GADD45B/GADD45A/CDK2/CDKN1A/IL6/MYC/CCNB2,7
Human Diseases,Cancer: specific types,hsa05224,Breast cancer,9/225,74/2914,0.12162162162162163,1.5751351351351353,1.4494147935333181,0.11322844511767263,0.436738288311023,0.3711849779797389,WNT8A/FGF20/GADD45B/GADD45A/CDKN1A/DLL4/MYC/FGF2/WNT7B,9
Metabolism,Carbohydrate metabolism,hsa00052,Galactose metabolism,2/225,8/2914,0.25,3.2377777777777776,1.8330750469738453,0.12204285928877823,0.4641066479995791,0.3944454162335605,SI/HK2,2
Organismal Systems,Immune system,hsa04659,Th17 cell differentiation,5/225,35/2914,0.14285714285714285,1.8501587301587301,1.4634547846479877,0.1282596198826013,0.4809735745597548,0.4087806598597527,IL4R/IL1R1/IL1B/IL6/RUNX1,5
Organismal Systems,Immune system,hsa04623,Cytosolic DNA-sensing pathway,4/225,27/2914,0.14814814814814814,1.9186831275720164,1.387044295752315,0.15045886919957718,0.548971549782241,0.4665723113159008,IL1B/IL6/IFNA5/IFI16,4
Human Diseases,Cancer: specific types,hsa05213,Endometrial cancer,4/225,27/2914,0.14814814814814814,1.9186831275720164,1.387044295752315,0.15045886919957718,0.548971549782241,0.4665723113159008,GADD45B/GADD45A/CDKN1A/MYC,4
Human Diseases,Cancer: specific types,hsa05217,Basal cell carcinoma,5/225,37/2914,0.13513513513513514,1.7501501501501502,1.3281442055890005,0.15249666385900382,0.5489879898924137,0.46658628380719763,WNT8A/GADD45B/GADD45A/CDKN1A/WNT7B,5
Environmental Information Processing,Signaling molecules and interaction,hsa04512,ECM-receptor interaction,7/225,58/2914,0.1206896551724138,1.5630651340996171,1.2527362119554095,0.15616859524097715,0.5548094830929452,0.47153398563065124,SPP1/COL4A2/THBS1/MEPE/ITGA5/COL4A1/ITGB3,7
Human Diseases,Cancer: specific types,hsa05210,Colorectal cancer,5/225,38/2914,0.13157894736842105,1.7040935672514619,1.2635540794831324,0.16528511707894158,0.5795711897573277,0.4925790228736743,GADD45B/GADD45A/CDKN1A/RAC2/MYC,5
Human Diseases,Neurodegenerative disease,hsa05020,Prion disease,9/225,81/2914,0.1111111111111111,1.4390123456790123,1.1589429443955006,0.16919247342338206,0.5796312649923188,0.4926300809681306,NDUFS1/NCF2/EGR1/IL1B/RAC2/IL6/CREB3L1/TUBB6/CASP12,9
Human Diseases,Infectious disease: viral,hsa05165,Human papillomavirus infection,15/225,149/2914,0.10067114093959731,1.3038031319910512,1.101042070247704,0.17109157375333003,0.5796312649923188,0.4926300809681306,WNT8A/TNFRSF1A/VEGFA/SPP1/CDK2/CDKN1A/IRF1/COL4A2/THBS1/IFNA5/CREB3L1/ITGA5/COL4A1/WNT7B/ITGB3,15
Metabolism,Glycan biosynthesis and metabolism,hsa00532,Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate,2/225,10/2914,0.2,2.5902222222222226,1.4568861422728538,0.17745015790020585,0.5796312649923188,0.4926300809681306,CHST3/CHSY1,2
Human Diseases,Endocrine and metabolic disease,hsa04940,Type I diabetes mellitus,2/225,10/2914,0.2,2.5902222222222226,1.4568861422728538,0.17745015790020585,0.5796312649923188,0.4926300809681306,IL1B/IL12A,2
Human Diseases,Immune disease,hsa05332,Graft-versus-host disease,2/225,10/2914,0.2,2.5902222222222226,1.4568861422728538,0.17745015790020585,0.5796312649923188,0.4926300809681306,IL1B/IL6,2
Cellular Processes,Transport and catabolism,hsa04148,Efferocytosis,8/225,71/2914,0.11267605633802817,1.4592801251956182,1.1331424174933442,0.17818294442356467,0.5796312649923188,0.4926300809681306,DUSP4/THBS1/CH25H/DUSP2/CX3CR1/P2RY12/P2RY6/ITGB3,8
Cellular Processes,Cell growth and death,hsa04110,Cell cycle,6/225,50/2914,0.12,1.5541333333333334,1.1430859088261482,0.1847774691510478,0.5939275794140823,0.5047805548236645,GADD45B/GADD45A/CDK2/CDKN1A/MYC/CCNB2,6
Human Diseases,Cancer: overview,hsa05204,Chemical carcinogenesis - DNA adducts,3/225,20/2914,0.15,1.9426666666666665,1.2234605918151729,0.19693481371177568,0.6192206060532015,0.526277162259641,CYP3A43/CYP1B1/HPGDS,3
Environmental Information Processing,Signal transduction,hsa04370,VEGF signaling pathway,4/225,30/2914,0.13333333333333333,1.7268148148148146,1.157318433801882,0.19731607899452847,0.6192206060532015,0.526277162259641,SH2D2A/VEGFA/RAC2/NOS3,4
Human Diseases,Endocrine and metabolic disease,hsa04932,Non-alcoholic fatty liver disease,5/225,41/2914,0.12195121951219512,1.5794037940379404,1.0806163900519576,0.2060040182977379,0.6192206060532015,0.526277162259641,NDUFS1/TNFRSF1A/IL1B/IL6/SOCS3,5
Human Diseases,Drug resistance: antineoplastic,hsa01523,Antifolate resistance,2/225,11/2914,0.18181818181818182,2.354747474747475,1.301958901080554,0.2064068686844005,0.6192206060532015,0.526277162259641,IL1B/IL6,2
Environmental Information Processing,Signal transduction,hsa04392,Hippo signaling pathway - multiple species,2/225,11/2914,0.18181818181818182,2.354747474747475,1.301958901080554,0.2064068686844005,0.6192206060532015,0.526277162259641,TEAD3/TEAD4,2
Human Diseases,Endocrine and metabolic disease,hsa04950,Maturity onset diabetes of the young,2/225,11/2914,0.18181818181818182,2.354747474747475,1.301958901080554,0.2064068686844005,0.6192206060532015,0.526277162259641,HHEX/RFX6,2
NA,NA,hsa04382,Cornified envelope formation,7/225,63/2914,0.1111111111111111,1.4390123456790123,1.0188599704082946,0.209665755273016,0.6220852079529047,0.5287117946734239,COL4A2/S100A8/S100A9/KRT80/ALOX12B/COL4A1/S100A3,7
Organismal Systems,Circulatory system,hsa04270,Vascular smooth muscle contraction,7/225,65/2914,0.1076923076923077,1.394735042735043,0.930855430475095,0.23279031023376068,0.6831889539469064,0.5806440232375267,EDN1/ACTA2/CALCA/EDN3/PLA2G5/RAMP2/ADM,7
Cellular Processes,Cell growth and death,hsa04215,Apoptosis - multiple species,2/225,12/2914,0.16666666666666666,2.1585185185185183,1.1630837806014218,0.23581244339738905,0.6846167711537101,0.5818575286998394,NGFR/TNFRSF1A,2
Organismal Systems,Digestive system,hsa04973,Carbohydrate digestion and absorption,3/225,22/2914,0.13636363636363635,1.7660606060606059,1.043137182587755,0.23861193883197016,0.6853747179216164,0.5825017095786058,SI/SLC2A5/HK2,3
Human Diseases,Infectious disease: bacterial,hsa05135,Yersinia infection,7/225,66/2914,0.10606060606060606,1.3736026936026937,0.8879286604028647,0.24466467304452807,0.6953627549686587,0.5909905675757022,CCL2/IL1B/RAC2/IL6/FCGR2A/ITGA5/CD8B2,7
Metabolism,Amino acid metabolism,hsa00220,Arginine biosynthesis,2/225,13/2914,0.15384615384615385,1.9924786324786325,1.0372539023963758,0.2654262024310703,0.7465111943373852,0.6344617558111111,NOS3/ACY1,2
Human Diseases,Infectious disease: viral,hsa05160,Hepatitis C,6/225,57/2914,0.10526315789473684,1.3632748538011694,0.8010944898835376,0.2748691300084849,0.7650996402298033,0.6502601230803008,TNFRSF1A/CDK2/CDKN1A/MYC/IFNA5/SOCS3,6
Organismal Systems,Endocrine system,hsa04926,Relaxin signaling pathway,7/225,69/2914,0.10144927536231885,1.3138808373590982,0.7631577392416417,0.281350703833515,0.7721171592440785,0.6562243302737198,EDN1/ACTA2/VEGFA/COL4A2/CREB3L1/NOS3/COL4A1,7
Organismal Systems,Immune system,hsa04662,B cell receptor signaling pathway,4/225,35/2914,0.11428571428571428,1.480126984126984,0.8264858163934341,0.28310962505616216,0.7721171592440785,0.6562243302737198,BLNK/CR2/RAC2/CARD11,4
Organismal Systems,Immune system,hsa04062,Chemokine signaling pathway,8/225,82/2914,0.0975609756097561,1.2635230352303524,0.7000756720031462,0.2971475263575183,0.8022983211652994,0.681875376273042,CXCL2/HCK/CCL2/RAC2/CXCR1/CCR1/CX3CR1/CXCR2,8
Cellular Processes,Cell growth and death,hsa04216,Ferroptosis,3/225,25/2914,0.12,1.5541333333333334,0.8047789515198408,0.30337265557542814,0.8030452647584863,0.682510205525731,CP/SLC39A14/ACSL5,3
Organismal Systems,Immune system,hsa04672,Intestinal immune network for IgA production,3/225,25/2914,0.12,1.5541333333333334,0.8047789515198408,0.30337265557542814,0.8030452647584863,0.682510205525731,IL15RA/IL6/TNFRSF13C,3
Metabolism,Lipid metabolism,hsa00590,Arachidonic acid metabolism,3/225,26/2914,0.11538461538461539,1.4943589743589742,0.7323127614783713,0.3252160415340183,0.8432885247112819,0.7167130541405826,PLA2G5/HPGDS/ALOX12B,3
Environmental Information Processing,Signal transduction,hsa04350,TGF-beta signaling pathway,5/225,49/2914,0.10204081632653061,1.321541950113379,0.6565071623351486,0.32659985467162483,0.8432885247112819,0.7167130541405826,HAMP/MYC/LRRC32/THBS1/NRROS,5
Organismal Systems,Immune system,hsa04611,Platelet activation,6/225,61/2914,0.09836065573770492,1.273879781420765,0.6252304264413778,0.3304259201168974,0.8432885247112819,0.7167130541405826,F2RL3/FCGR2A/FCER1G/NOS3/P2RY12/ITGB3,6
Metabolism,Lipid metabolism,hsa00061,Fatty acid biosynthesis,1/225,5/2914,0.2,2.5902222222222226,1.029288356353312,0.33106882821998473,0.8432885247112819,0.7167130541405826,ACSL5,1
Metabolism,Amino acid metabolism,hsa00380,Tryptophan metabolism,2/225,16/2914,0.125,1.6188888888888888,0.7179423739553533,0.3536002685298364,0.8922623598416433,0.7583360407231121,IL4I1/CYP1B1,2
Environmental Information Processing,Signaling molecules and interaction,hsa04080,Neuroactive ligand-receptor interaction,17/225,198/2914,0.08585858585858586,1.1119640852974186,0.4719679946485844,0.3580017229534978,0.8950043073837445,0.760666428887549,EDN1/NTSR1/CALCA/PRLHR/EDN3/F2RL3/CHRNA10/HCRTR2/GABRA6/ADM/BDKRB2/FPR2/FPR1/P2RY6/CYSLTR1/P2RY13/C5AR1,17
Metabolism,Amino acid metabolism,hsa00310,Lysine degradation,2/225,17/2914,0.11764705882352941,1.5236601307189541,0.6262760779556535,0.38226902073984736,0.9146741982752896,0.7773839190020005,PRDM7/PLOD2,2
Metabolism,Lipid metabolism,hsa00120,Primary bile acid biosynthesis,1/225,6/2914,0.16666666666666666,2.1585185185185183,0.8215755468985616,0.38280809038928787,0.9146741982752896,0.7773839190020005,CH25H,1
Metabolism,Metabolism of cofactors and vitamins,hsa00860,Porphyrin metabolism,1/225,6/2914,0.16666666666666666,2.1585185185185183,0.8215755468985616,0.38280809038928787,0.9146741982752896,0.7773839190020005,CP,1
NA,NA,hsa03273,Virion - Lassa virus and SFTS virus,1/225,6/2914,0.16666666666666666,2.1585185185185183,0.8215755468985616,0.38280809038928787,0.9146741982752896,0.7773839190020005,CD209,1
Human Diseases,Immune disease,hsa05310,Asthma,1/225,6/2914,0.16666666666666666,2.1585185185185183,0.8215755468985616,0.38280809038928787,0.9146741982752896,0.7773839190020005,FCER1G,1
Organismal Systems,Endocrine system,hsa04920,Adipocytokine signaling pathway,3/225,29/2914,0.10344827586206896,1.3397701149425287,0.5318355544478798,0.39048794551228505,0.9248398709501487,0.7860237499693272,TNFRSF1A/SOCS3/ACSL5,3
Human Diseases,Cancer: overview,hsa05207,Chemical carcinogenesis - receptor activation,7/225,78/2914,0.08974358974358974,1.1622792022792021,0.42016817323006383,0.39726495814673213,0.9265974184225754,0.7875174940199666,FGF20/VEGFA/DLL4/MYC/CYP1B1/FGF2/CREB3L1,7
Cellular Processes,Cellular community - eukaryotes,hsa04510,Focal adhesion,9/225,103/2914,0.08737864077669903,1.1316504854368932,0.393438408501402,0.40020490884933313,0.9265974184225754,0.7875174940199666,VEGFA/SPP1/RAC2/EMP1/COL4A2/THBS1/ITGA5/COL4A1/ITGB3,9
Human Diseases,Cancer: specific types,hsa05225,Hepatocellular carcinoma,6/225,66/2914,0.09090909090909091,1.1773737373737374,0.421558055425585,0.401525547983116,0.9265974184225754,0.7875174940199666,WNT8A/GADD45B/GADD45A/CDKN1A/MYC/WNT7B,6
Environmental Information Processing,Signal transduction,hsa04071,Sphingolipid signaling pathway,5/225,54/2914,0.09259259259259259,1.1991769547325102,0.42728638196811564,0.4056674658462668,0.9282221676143393,0.788898372475345,TNFRSF1A/RAC2/FCER1G/NOS3/BDKRB2,5
Metabolism,Metabolism of cofactors and vitamins,hsa00760,Nicotinate and nicotinamide metabolism,2/225,18/2914,0.1111111111111111,1.4390123456790123,0.5403557876382531,0.4103848331743203,0.9311252517400544,0.7913657110305337,NAMPT/PNP,2
Environmental Information Processing,Signal transduction,hsa04014,Ras signaling pathway,9/225,105/2914,0.08571428571428572,1.110095238095238,0.33231765546248204,0.4230501796328485,0.9518629041739092,0.8089906943856227,NGFR/FGF20/ANGPT2/VEGFA/PLA2G5/RAC2/FGF2/EPHA2/EFNA1,9
Organismal Systems,Endocrine system,hsa04917,Prolactin signaling pathway,3/225,31/2914,0.0967741935483871,1.2533333333333334,0.41012568007060496,0.433177937126046,0.9586724838035445,0.8147781733690943,CISH/IRF1/SOCS3,3
Human Diseases,Cancer: specific types,hsa05215,Prostate cancer,3/225,31/2914,0.0967741935483871,1.2533333333333334,0.41012568007060496,0.433177937126046,0.9586724838035445,0.8147781733690943,CDK2/CDKN1A/CREB3L1,3
Organismal Systems,Endocrine system,hsa04910,Insulin signaling pathway,5/225,56/2914,0.08928571428571429,1.1563492063492065,0.34168403144171505,0.43713105720024126,0.9595559792200419,0.8155290583624527,PYGL/TRIP10/HK2/PPP1R3B/SOCS3,5
Human Diseases,Cancer: specific types,hsa05214,Glioma,3/225,32/2914,0.09375,1.2141666666666666,0.3523270426422814,0.4541210538546835,0.9710582395168496,0.8253048585367376,GADD45B/GADD45A/CDKN1A,3
Human Diseases,Endocrine and metabolic disease,hsa04934,Cushing syndrome,6/225,70/2914,0.08571428571428572,1.110095238095238,0.26966144615635246,0.4582157920415024,0.9710582395168496,0.8253048585367376,WNT8A/NR4A1/CDK2/CDKN1A/CREB3L1/WNT7B,6
Metabolism,Metabolism of cofactors and vitamins,hsa00830,Retinol metabolism,2/225,20/2914,0.1,1.2951111111111113,0.38301642289734783,0.46463187519058424,0.9710582395168496,0.8253048585367376,DHRS9/BCO1,2
Human Diseases,Endocrine and metabolic disease,hsa04930,Type II diabetes mellitus,2/225,20/2914,0.1,1.2951111111111113,0.38301642289734783,0.46463187519058424,0.9710582395168496,0.8253048585367376,HK2/SOCS3,2
Metabolism,Lipid metabolism,hsa00592,alpha-Linolenic acid metabolism,1/225,8/2914,0.125,1.6188888888888888,0.506962661948576,0.4746360884900722,0.9710582395168496,0.8253048585367376,PLA2G5,1
Metabolism,Metabolism of cofactors and vitamins,hsa00770,Pantothenate and CoA biosynthesis,1/225,8/2914,0.125,1.6188888888888888,0.506962661948576,0.4746360884900722,0.9710582395168496,0.8253048585367376,VNN2,1
Metabolism,Global and overview maps,hsa01210,2-Oxocarboxylic acid metabolism,1/225,8/2914,0.125,1.6188888888888888,0.506962661948576,0.4746360884900722,0.9710582395168496,0.8253048585367376,ACY1,1
Human Diseases,Immune disease,hsa05330,Allograft rejection,1/225,8/2914,0.125,1.6188888888888888,0.506962661948576,0.4746360884900722,0.9710582395168496,0.8253048585367376,IL12A,1
Human Diseases,Cancer: specific types,hsa05223,Non-small cell lung cancer,3/225,33/2914,0.09090909090909091,1.1773737373737374,0.2963744479450005,0.4747395837637931,0.9710582395168496,0.8253048585367376,GADD45B/GADD45A/CDKN1A,3
Human Diseases,Infectious disease: parasitic,hsa05145,Toxoplasmosis,4/225,46/2914,0.08695652173913043,1.126183574879227,0.24949294517928738,0.48008390493633635,0.9743656468325468,0.8281158323956929,TNFRSF1A/TLR2/LY96/IL12A,4
Human Diseases,Cardiovascular disease,hsa05415,Diabetic cardiomyopathy,5/225,59/2914,0.0847457627118644,1.0975517890772128,0.2189395839453247,0.4835740617613381,0.9743656468325468,0.8281158323956929,NDUFS1/NCF2/RAC2/NOS3/PLN,5
Human Diseases,Infectious disease: bacterial,hsa05120,Epithelial cell signaling in Helicobacter pylori infection,3/225,34/2914,0.08823529411764706,1.1427450980392158,0.2421422190725097,0.4949970452627642,0.9899940905255284,0.8413984862946012,CXCL2/CXCR1/CXCR2,3
Human Diseases,Infectious disease: bacterial,hsa05131,Shigellosis,7/225,87/2914,0.08045977011494253,1.042043422733078,0.11514918986059157,0.5134368762257262,0.9996715223698593,0.8496233601428045,TNFRSF1A/IL1R1/IL1B/HK2/ITGA5/CD14/CASP4,7
Human Diseases,Drug resistance: antineoplastic,hsa01521,EGFR tyrosine kinase inhibitor resistance,3/225,35/2914,0.08571428571428572,1.110095238095238,0.18951684813888045,0.514861490907133,0.9996715223698593,0.8496233601428045,VEGFA/IL6/FGF2,3
Metabolism,Lipid metabolism,hsa00565,Ether lipid metabolism,2/225,22/2914,0.09090909090909091,1.1773737373737374,0.241528071284823,0.5158419049203928,0.9996715223698593,0.8496233601428045,PLA2G5/PLD4,2
Metabolism,Xenobiotics biodegradation and metabolism,hsa00980,Metabolism of xenobiotics by cytochrome P450,2/225,22/2914,0.09090909090909091,1.1773737373737374,0.241528071284823,0.5158419049203928,0.9996715223698593,0.8496233601428045,CYP1B1/HPGDS,2
Cellular Processes,Cell motility,hsa04810,Regulation of actin cytoskeleton,8/225,101/2914,0.07920792079207921,1.0258305830583059,0.07641456240372145,0.5250773993457556,0.9996715223698593,0.8496233601428045,FGF20/RAC2/FGF2/ITGA5/BDKRB2/LIMK2/ITGB3/CYFIP1,8
Organismal Systems,Immune system,hsa04658,Th1 and Th2 cell differentiation,3/225,36/2914,0.08333333333333333,1.0792592592592591,0.13839549872113785,0.5343052594999538,0.9996715223698593,0.8496233601428045,IL4R/DLL4/IL12A,3
Organismal Systems,Digestive system,hsa04974,Protein digestion and absorption,4/225,50/2914,0.08,1.0360888888888888,0.0744454409662202,0.5472775574392652,0.9996715223698593,0.8496233601428045,SLC1A5/COL4A2/CPB1/COL4A1,4
Genetic Information Processing,Translation,hsa03008,Ribosome biogenesis in eukaryotes,1/225,10/2914,0.1,1.2951111111111113,0.27036679666550445,0.5528532298524446,0.9996715223698593,0.8496233601428045,SNORD3B-1,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04130,SNARE interactions in vesicular transport,1/225,10/2914,0.1,1.2951111111111113,0.27036679666550445,0.5528532298524446,0.9996715223698593,0.8496233601428045,STX11,1
Human Diseases,Cardiovascular disease,hsa05410,Hypertrophic cardiomyopathy,4/225,51/2914,0.0784313725490196,1.0157734204793027,0.03286747906311981,0.5633717765406658,0.9996715223698593,0.8496233601428045,EDN1/IL6/ITGA5/ITGB3,4
Cellular Processes,Cellular community - eukaryotes,hsa04550,Signaling pathways regulating pluripotency of stem cells,5/225,65/2914,0.07692307692307693,0.9962393162393163,-0.00886836110793885,0.5719334984845812,0.9996715223698593,0.8496233601428045,WNT8A/LIF/MYC/FGF2/WNT7B,5
Cellular Processes,Cell motility,hsa04820,Cytoskeleton in muscle cells,9/225,119/2914,0.07563025210084033,0.9794957983193276,-0.06605284677777638,0.5782027865530563,0.9996715223698593,0.8496233601428045,PDLIM1/MYBPH/DSC2/COL4A2/THBS1/ITGA5/XIRP1/COL4A1/ITGB3,9
Human Diseases,Cancer: overview,hsa05208,Chemical carcinogenesis - reactive oxygen species,5/225,66/2914,0.07575757575757576,0.9811447811447811,-0.04481254955169466,0.5859013632797831,0.9996715223698593,0.8496233601428045,NDUFS1/VEGFA/NCF2/CYP1B1/SLC26A9,5
Organismal Systems,Immune system,hsa04622,RIG-I-like receptor signaling pathway,2/225,25/2914,0.08,1.0360888888888888,0.052412616990223905,0.586357149003075,0.9996715223698593,0.8496233601428045,IFNA5/IL12A,2
Human Diseases,Cancer: specific types,hsa05211,Renal cell carcinoma,2/225,25/2914,0.08,1.0360888888888888,0.052412616990223905,0.586357149003075,0.9996715223698593,0.8496233601428045,VEGFA/CDKN1A,2
Metabolism,Amino acid metabolism,hsa00360,Phenylalanine metabolism,1/225,11/2914,0.09090909090909091,1.1773737373737374,0.1704622599386708,0.587497865969249,0.9996715223698593,0.8496233601428045,IL4I1,1
Metabolism,Lipid metabolism,hsa00591,Linoleic acid metabolism,1/225,11/2914,0.09090909090909091,1.1773737373737374,0.1704622599386708,0.587497865969249,0.9996715223698593,0.8496233601428045,PLA2G5,1
Human Diseases,Substance dependence,hsa05031,Amphetamine addiction,3/225,39/2914,0.07692307692307693,0.9962393162393163,-0.006838270781914774,0.5898948273622519,0.9996715223698593,0.8496233601428045,FOSB/CREB3L1/ARC,3
Human Diseases,Infectious disease: viral,hsa05170,Human immunodeficiency virus 1 infection,6/225,80/2914,0.075,0.9713333333333333,-0.07519489674687957,0.5922070444972491,0.9996715223698593,0.8496233601428045,TNFRSF1A/RAC2/TLR2/IFNA5/CCNB2/LIMK2,6
Organismal Systems,Immune system,hsa04670,Leukocyte transendothelial migration,4/225,53/2914,0.07547169811320754,0.9774423480083858,-0.04793348422325093,0.5946050230796641,0.9996715223698593,0.8496233601428045,ICAM1/NCF2/RAC2/CDH5,4
Organismal Systems,Endocrine system,hsa04916,Melanogenesis,4/225,53/2914,0.07547169811320754,0.9774423480083858,-0.04793348422325093,0.5946050230796641,0.9996715223698593,0.8496233601428045,WNT8A/EDN1/CREB3L1/WNT7B,4
Human Diseases,Neurodegenerative disease,hsa05010,Alzheimer disease,9/225,121/2914,0.0743801652892562,0.9633057851239669,-0.11923971171295844,0.5989651865998171,0.9996715223698593,0.8496233601428045,NDUFS1/WNT8A/TNFRSF1A/SLC39A14/IL1B/IL6/TUBB6/WNT7B/CASP12,9
Organismal Systems,Environmental adaptation,hsa04710,Circadian rhythm,1/225,12/2914,0.08333333333333333,1.0792592592592591,0.07957158857055764,0.6194692680212363,0.9996715223698593,0.8496233601428045,NFIL3,1
Human Diseases,Immune disease,hsa05320,Autoimmune thyroid disease,1/225,12/2914,0.08333333333333333,1.0792592592592591,0.07957158857055764,0.6194692680212363,0.9996715223698593,0.8496233601428045,IFNA5,1
Human Diseases,Immune disease,hsa05322,Systemic lupus erythematosus,4/225,55/2914,0.07272727272727272,0.9418989898989898,-0.1258125747035665,0.6244874679605996,0.9996715223698593,0.8496233601428045,FCGR2A/FCGR1A/FCGR3B/FCGR3A,4
Environmental Information Processing,Signal transduction,hsa04310,Wnt signaling pathway,6/225,83/2914,0.07228915662650602,0.9362248995983935,-0.17048507412901553,0.6289587032704181,0.9996715223698593,0.8496233601428045,WNT8A/RAC2/LGR6/MYC/FOSL1/WNT7B,6
Human Diseases,Cardiovascular disease,hsa05416,Viral myocarditis,2/225,27/2914,0.07407407407407407,0.9593415637860082,-0.06138683767260749,0.6290035655494703,0.9996715223698593,0.8496233601428045,ICAM1/RAC2,2
Environmental Information Processing,Signal transduction,hsa04390,Hippo signaling pathway,5/225,70/2914,0.07142857142857142,0.9250793650793651,-0.18350663579267384,0.6392139166100601,0.9996715223698593,0.8496233601428045,TEAD3/WNT8A/MYC/WNT7B/TEAD4,5
Organismal Systems,Immune system,hsa04664,Fc epsilon RI signaling pathway,2/225,28/2914,0.07142857142857142,0.9250793650793651,-0.11521218198357737,0.6490162437512184,0.9996715223698593,0.8496233601428045,RAC2/FCER1G,2
Organismal Systems,Endocrine system,hsa04922,Glucagon signaling pathway,3/225,43/2914,0.06976744186046512,0.9035658914728681,-0.18425292961594095,0.6570914437150539,0.9996715223698593,0.8496233601428045,PYGL/CREB3L1/LOC102724428,3
Human Diseases,Substance dependence,hsa05030,Cocaine addiction,2/225,29/2914,0.06896551724137931,0.8931800766283524,-0.16720314905285164,0.6681664880652132,0.9996715223698593,0.8496233601428045,FOSB/CREB3L1,2
Environmental Information Processing,Signal transduction,hsa04020,Calcium signaling pathway,10/225,142/2914,0.07042253521126761,0.9120500782472615,-0.31077717665076643,0.6696211413225537,0.9996715223698593,0.8496233601428045,FGF20/ITPKC/NTSR1/VEGFA/FGF2/MST1R/NOS3/BDKRB2/CYSLTR1/PLN,10
Metabolism,Carbohydrate metabolism,hsa00051,Fructose and mannose metabolism,1/225,14/2914,0.07142857142857142,0.9250793650793651,-0.08127043200733916,0.6761983332821218,0.9996715223698593,0.8496233601428045,HK2,1
Metabolism,Lipid metabolism,hsa00071,Fatty acid degradation,1/225,14/2914,0.07142857142857142,0.9250793650793651,-0.08127043200733916,0.6761983332821218,0.9996715223698593,0.8496233601428045,ACSL5,1
Metabolism,Amino acid metabolism,hsa00280,"Valine, leucine and isoleucine degradation",1/225,14/2914,0.07142857142857142,0.9250793650793651,-0.08127043200733916,0.6761983332821218,0.9996715223698593,0.8496233601428045,IL4I1,1
Metabolism,Global and overview maps,hsa01250,Biosynthesis of nucleotide sugars,1/225,14/2914,0.07142857142857142,0.9250793650793651,-0.08127043200733916,0.6761983332821218,0.9996715223698593,0.8496233601428045,HK2,1
Organismal Systems,Endocrine system,hsa03320,PPAR signaling pathway,2/225,30/2914,0.06666666666666667,0.8634074074074073,-0.21749849082049233,0.6864675596244085,0.9996715223698593,0.8496233601428045,ANGPTL4/ACSL5,2
Metabolism,Glycan biosynthesis and metabolism,hsa00512,Mucin type O-glycan biosynthesis,1/225,15/2914,0.06666666666666667,0.8634074074074073,-0.15339625973585594,0.7013208763895433,0.9996715223698593,0.8496233601428045,GALNT5,1
Metabolism,Carbohydrate metabolism,hsa00520,Amino sugar and nucleotide sugar metabolism,1/225,15/2914,0.06666666666666667,0.8634074074074073,-0.15339625973585594,0.7013208763895433,0.9996715223698593,0.8496233601428045,HK2,1
Organismal Systems,Endocrine system,hsa04919,Thyroid hormone signaling pathway,3/225,46/2914,0.06521739130434782,0.8446376811594203,-0.3071858008026757,0.7020768490340048,0.9996715223698593,0.8496233601428045,MYC/PLN/ITGB3,3
Human Diseases,Cardiovascular disease,hsa05412,Arrhythmogenic right ventricular cardiomyopathy,3/225,47/2914,0.06382978723404255,0.8266666666666665,-0.3464840695568665,0.7160411256145115,0.9996715223698593,0.8496233601428045,DSC2/ITGA5/ITGB3,3
Cellular Processes,Cellular community - eukaryotes,hsa04520,Adherens junction,2/225,32/2914,0.0625,0.8094444444444444,-0.3134842428697859,0.720590126491695,0.9996715223698593,0.8496233601428045,RAC2/CDH5,2
Metabolism,Amino acid metabolism,hsa00350,Tyrosine metabolism,1/225,16/2914,0.0625,0.8094444444444444,-0.22105407025734838,0.7245022502468572,0.9996715223698593,0.8496233601428045,IL4I1,1
Metabolism,Glycan biosynthesis and metabolism,hsa00514,Other types of O-glycan biosynthesis,1/225,16/2914,0.0625,0.8094444444444444,-0.22105407025734838,0.7245022502468572,0.9996715223698593,0.8496233601428045,GALNT5,1
Metabolism,Global and overview maps,hsa01212,Fatty acid metabolism,1/225,16/2914,0.0625,0.8094444444444444,-0.22105407025734838,0.7245022502468572,0.9996715223698593,0.8496233601428045,ACSL5,1
Genetic Information Processing,Transcription,hsa03040,Spliceosome,1/225,16/2914,0.0625,0.8094444444444444,-0.22105407025734838,0.7245022502468572,0.9996715223698593,0.8496233601428045,RNVU1-27,1
Organismal Systems,Excretory system,hsa04962,Vasopressin-regulated water reabsorption,1/225,16/2914,0.0625,0.8094444444444444,-0.22105407025734838,0.7245022502468572,0.9996715223698593,0.8496233601428045,CREB3L1,1
Organismal Systems,Endocrine system,hsa04928,"Parathyroid hormone synthesis, secretion and action",3/225,48/2914,0.0625,0.8094444444444444,-0.38500843185544753,0.729496685379699,0.9996715223698593,0.8496233601428045,EGR1/CDKN1A/CREB3L1,3
Metabolism,Amino acid metabolism,hsa00250,"Alanine, aspartate and glutamate metabolism",1/225,17/2914,0.058823529411764705,0.7618300653594771,-0.2848414912718924,0.7458918270910453,0.9996715223698593,0.8496233601428045,IL4I1,1
Metabolism,Xenobiotics biodegradation and metabolism,hsa00982,Drug metabolism - cytochrome P450,1/225,17/2914,0.058823529411764705,0.7618300653594771,-0.2848414912718924,0.7458918270910453,0.9996715223698593,0.8496233601428045,HPGDS,1
Organismal Systems,Immune system,hsa04612,Antigen processing and presentation,1/225,17/2914,0.058823529411764705,0.7618300653594771,-0.2848414912718924,0.7458918270910453,0.9996715223698593,0.8496233601428045,CD8B2,1
Organismal Systems,Digestive system,hsa04975,Fat digestion and absorption,1/225,17/2914,0.058823529411764705,0.7618300653594771,-0.2848414912718924,0.7458918270910453,0.9996715223698593,0.8496233601428045,PLA2G5,1
Organismal Systems,Endocrine system,hsa04927,Cortisol synthesis and secretion,2/225,34/2914,0.058823529411764705,0.7618300653594771,-0.4040138490385649,0.7515423522393676,0.9996715223698593,0.8496233601428045,NR4A1/CREB3L1,2
Environmental Information Processing,Signal transduction,hsa04371,Apelin signaling pathway,4/225,66/2914,0.06060606060606061,0.784915824915825,-0.5111831545289743,0.7627148367141877,0.9996715223698593,0.8496233601428045,ACTA2/SPP1/EGR1/NOS3,4
Metabolism,Metabolism of cofactors and vitamins,hsa00670,One carbon pool by folate,1/225,18/2914,0.05555555555555555,0.7195061728395061,-0.34524419277674656,0.7656275326155586,0.9996715223698593,0.8496233601428045,MTHFD2,1
Organismal Systems,Endocrine system,hsa04924,Renin secretion,2/225,36/2914,0.05555555555555555,0.7195061728395061,-0.48977347834022583,0.7795090814164818,0.9996715223698593,0.8496233601428045,EDN1/EDN3,2
Human Diseases,Cancer: overview,hsa05203,Viral carcinogenesis,4/225,68/2914,0.058823529411764705,0.7618300653594771,-0.5747646454193976,0.7830689599585451,0.9996715223698593,0.8496233601428045,EGR2/CDK2/CDKN1A/CREB3L1,4
Metabolism,Lipid metabolism,hsa00140,Steroid hormone biosynthesis,1/225,19/2914,0.05263157894736842,0.6816374269005847,-0.40266197822983424,0.7838367194807171,0.9996715223698593,0.8496233601428045,CYP1B1,1
Human Diseases,Cardiovascular disease,hsa05414,Dilated cardiomyopathy,3/225,54/2914,0.05555555555555555,0.7195061728395061,-0.6017322271683219,0.7999672315523652,0.9996715223698593,0.8496233601428045,ITGA5/PLN/ITGB3,3
Metabolism,Amino acid metabolism,hsa00330,Arginine and proline metabolism,1/225,20/2914,0.05,0.6475555555555557,-0.4574277460204771,0.8006369744433557,0.9996715223698593,0.8496233601428045,NOS3,1
Metabolism,Amino acid metabolism,hsa00270,Cysteine and methionine metabolism,1/225,21/2914,0.047619047619047616,0.6167195767195767,-0.5098215256464541,0.8161368641289968,0.9996715223698593,0.8496233601428045,IL4I1,1
Environmental Information Processing,Signaling molecules and interaction,hsa04514,Cell adhesion molecules,5/225,88/2914,0.056818181818181816,0.7358585858585859,-0.727709184410452,0.822685635913049,0.9996715223698593,0.8496233601428045,SELE/ICAM1/SELPLG/CDH5/CD8B2,5
Metabolism,Lipid metabolism,hsa00564,Glycerophospholipid metabolism,2/225,40/2914,0.05,0.6475555555555557,-0.6491474915576215,0.8272927242545359,0.9996715223698593,0.8496233601428045,PLA2G5/PLD4,2
Organismal Systems,Endocrine system,hsa04914,Progesterone-mediated oocyte maturation,2/225,40/2914,0.05,0.6475555555555557,-0.6491474915576215,0.8272927242545359,0.9996715223698593,0.8496233601428045,CDK2/CCNB2,2
Organismal Systems,Digestive system,hsa04971,Gastric acid secretion,2/225,40/2914,0.05,0.6475555555555557,-0.6491474915576215,0.8272927242545359,0.9996715223698593,0.8496233601428045,KCNJ16/SLC9A4,2
Metabolism,Metabolism of other amino acids,hsa00480,Glutathione metabolism,1/225,22/2914,0.045454545454545456,0.5886868686868687,-0.5600810400181089,0.8304366240913111,0.9996715223698593,0.8496233601428045,HPGDS,1
Organismal Systems,Endocrine system,hsa04915,Estrogen signaling pathway,3/225,58/2914,0.05172413793103448,0.6698850574712644,-0.7344566686314512,0.8379086236981745,0.9996715223698593,0.8496233601428045,FKBP5/CREB3L1/NOS3,3
Cellular Processes,Transport and catabolism,hsa04146,Peroxisome,1/225,23/2914,0.043478260869565216,0.5630917874396135,-0.6084097716792702,0.8436287954535016,0.9996715223698593,0.8496233601428045,ACSL5,1
Environmental Information Processing,Signal transduction,hsa04330,Notch signaling pathway,1/225,23/2914,0.043478260869565216,0.5630917874396135,-0.6084097716792702,0.8436287954535016,0.9996715223698593,0.8496233601428045,DLL4,1
Organismal Systems,Sensory system,hsa04750,Inflammatory mediator regulation of TRP channels,3/225,59/2914,0.05084745762711865,0.6585310734463278,-0.7663730764665314,0.8463708624475093,0.9996715223698593,0.8496233601428045,IL1R1/IL1B/BDKRB2,3
Metabolism,Global and overview maps,hsa01240,Biosynthesis of cofactors,2/225,42/2914,0.047619047619047616,0.6167195767195767,-0.7236276702127705,0.847523213321226,0.9996715223698593,0.8496233601428045,MTHFD2/BCO1,2
Cellular Processes,Transport and catabolism,hsa04144,Endocytosis,4/225,76/2914,0.05263157894736842,0.6816374269005847,-0.813371043085243,0.8509691017982073,0.9996715223698593,0.8496233601428045,ARAP3/VPS28/CXCR1/CXCR2,4
Metabolism,Carbohydrate metabolism,hsa00010,Glycolysis / Gluconeogenesis,1/225,24/2914,0.041666666666666664,0.5396296296296296,-0.6549832053166978,0.855798813102399,0.9996715223698593,0.8496233601428045,HK2,1
Cellular Processes,Cell growth and death,hsa04114,Oocyte meiosis,2/225,43/2914,0.046511627906976744,0.6023772609819121,-0.7597224225428993,0.8568125679361611,0.9996715223698593,0.8496233601428045,CDK2/CCNB2,2
Environmental Information Processing,Signal transduction,hsa04150,mTOR signaling pathway,3/225,61/2914,0.04918032786885246,0.6369398907103825,-0.8288170297838214,0.8621555160315616,0.9996715223698593,0.8496233601428045,WNT8A/TNFRSF1A/WNT7B,3
Organismal Systems,Environmental adaptation,hsa04714,Thermogenesis,3/225,61/2914,0.04918032786885246,0.6369398907103825,-0.8288170297838214,0.8621555160315616,0.9996715223698593,0.8496233601428045,NDUFS1/CREB3L1/ACSL5,3
Human Diseases,Drug resistance: antineoplastic,hsa01522,Endocrine resistance,2/225,44/2914,0.045454545454545456,0.5886868686868687,-0.7951042317021564,0.8655843835792505,0.9996715223698593,0.8496233601428045,CDKN1A/DLL4,2
Environmental Information Processing,Signal transduction,hsa04070,Phosphatidylinositol signaling system,2/225,44/2914,0.045454545454545456,0.5886868686868687,-0.7951042317021564,0.8655843835792505,0.9996715223698593,0.8496233601428045,ITPKC/IP6K3,2
Organismal Systems,Endocrine system,hsa04913,Ovarian steroidogenesis,1/225,25/2914,0.04,0.5180444444444444,-0.6999537175393931,0.8670255491065374,0.9996715223698593,0.8496233601428045,CYP1B1,1
Organismal Systems,Immune system,hsa04660,T cell receptor signaling pathway,2/225,45/2914,0.044444444444444446,0.575604938271605,-0.8298075937217465,0.8738627712651699,0.9996715223698593,0.8496233601428045,CARD11/CD8B2,2
Human Diseases,Substance dependence,hsa05033,Nicotine addiction,1/225,26/2914,0.038461538461538464,0.49811965811965814,-0.7434544494123438,0.8773818147524457,0.9996715223698593,0.8496233601428045,GABRA6,1
Organismal Systems,Development and regeneration,hsa04360,Axon guidance,5/225,97/2914,0.05154639175257732,0.6675830469644902,-0.9630341953460535,0.8814380354961628,0.9996715223698593,0.8496233601428045,RAC2/EPHA2/EFNA1/LIMK2/EPHB3,5
Environmental Information Processing,Signal transduction,hsa04012,ErbB signaling pathway,2/225,46/2914,0.043478260869565216,0.5630917874396135,-0.8638645467846388,0.8816712222756773,0.9996715223698593,0.8496233601428045,CDKN1A/MYC,2
Organismal Systems,Nervous system,hsa04727,GABAergic synapse,2/225,46/2914,0.043478260869565216,0.5630917874396135,-0.8638645467846388,0.8816712222756773,0.9996715223698593,0.8496233601428045,SLC38A5/GABRA6,2
NA,NA,hsa04081,Hormone signaling,6/225,114/2914,0.05263157894736842,0.6816374269005847,-1.0029089717144262,0.8865279366888821,0.9996715223698593,0.8496233601428045,HAMP/CALCA/PRLHR/RAMP2/HCRTR2/ITGB3,6
Human Diseases,Drug resistance: antineoplastic,hsa01524,Platinum drug resistance,1/225,27/2914,0.037037037037037035,0.4796707818930041,-0.7856024043850687,0.8869348243371755,0.9996715223698593,0.8496233601428045,CDKN1A,1
Organismal Systems,Digestive system,hsa04972,Pancreatic secretion,2/225,47/2914,0.0425531914893617,0.5511111111111111,-0.8973048980831673,0.8890325599050626,0.9996715223698593,0.8496233601428045,PLA2G5/CPB1,2
Cellular Processes,Cell motility,hsa04814,Motor proteins,4/225,82/2914,0.04878048780487805,0.6317615176151762,-0.9782628785663053,0.8893151639593806,0.9996715223698593,0.8496233601428045,ACTA2/MYO1G/TUBB6/KIF19,4
Metabolism,Global and overview maps,hsa01230,Biosynthesis of amino acids,1/225,28/2914,0.03571428571428571,0.46253968253968253,-0.82650094956863,0.895746623618137,0.9996715223698593,0.8496233601428045,ACY1,1
Genetic Information Processing,"Folding, sorting and degradation",hsa04141,Protein processing in endoplasmic reticulum,1/225,28/2914,0.03571428571428571,0.46253968253968253,-0.82650094956863,0.895746623618137,0.9996715223698593,0.8496233601428045,CASP12,1
Organismal Systems,Excretory system,hsa04961,Endocrine and other factor-regulated calcium reabsorption,1/225,28/2914,0.03571428571428571,0.46253968253968253,-0.82650094956863,0.895746623618137,0.9996715223698593,0.8496233601428045,BDKRB2,1
Metabolism,Energy metabolism,hsa00190,Oxidative phosphorylation,1/225,29/2914,0.034482758620689655,0.4465900383141762,-0.8662418525535831,0.9038744856021699,0.9996715223698593,0.8496233601428045,NDUFS1,1
Organismal Systems,Digestive system,hsa04979,Cholesterol metabolism,1/225,29/2914,0.034482758620689655,0.4465900383141762,-0.8662418525535831,0.9038744856021699,0.9996715223698593,0.8496233601428045,ANGPTL4,1
Human Diseases,Neurodegenerative disease,hsa05012,Parkinson disease,3/225,68/2914,0.04411764705882353,0.5713725490196079,-1.0343870868991243,0.9067573276389561,0.9996715223698593,0.8496233601428045,NDUFS1/SLC39A14/TUBB6,3
Environmental Information Processing,Signal transduction,hsa04024,cAMP signaling pathway,6/225,119/2914,0.05042016806722689,0.6529971988795519,-1.1178451719714415,0.9090760887115537,0.9996715223698593,0.8496233601428045,EDN1/ARAP3/EDN3/RAC2/CREB3L1/PLN,6
Organismal Systems,Nervous system,hsa04730,Long-term depression,1/225,30/2914,0.03333333333333333,0.43170370370370365,-0.9049069531316795,0.9113712761531272,0.9996715223698593,0.8496233601428045,PPP1R17,1
Human Diseases,Cancer: overview,hsa05235,PD-L1 expression and PD-1 checkpoint pathway in cancer,1/225,30/2914,0.03333333333333333,0.43170370370370365,-0.9049069531316795,0.9113712761531272,0.9996715223698593,0.8496233601428045,TLR2,1
Environmental Information Processing,Signal transduction,hsa04072,Phospholipase D signaling pathway,3/225,69/2914,0.043478260869565216,0.5630917874396135,-1.0622817453880677,0.9119409709787856,0.9996715223698593,0.8496233601428045,FCER1G/CXCR1/CXCR2,3
Organismal Systems,Endocrine system,hsa04925,Aldosterone synthesis and secretion,2/225,51/2914,0.0392156862745098,0.5078867102396514,-1.0254290291129136,0.9144380411889036,0.9996715223698593,0.8496233601428045,NR4A1/CREB3L1,2
Environmental Information Processing,Signal transduction,hsa04022,cGMP-PKG signaling pathway,4/225,88/2914,0.045454545454545456,0.5886868686868687,-1.1331670359156254,0.9187848315029672,0.9996715223698593,0.8496233601428045,CREB3L1/NOS3/BDKRB2/PLN,4
Genetic Information Processing,"Folding, sorting and degradation",hsa04120,Ubiquitin mediated proteolysis,1/225,32/2914,0.03125,0.4047222222222222,-0.9792955283818531,0.9246630712330013,0.9996715223698593,0.8496233601428045,SOCS3,1
Metabolism,Carbohydrate metabolism,hsa00562,Inositol phosphate metabolism,1/225,33/2914,0.030303030303030304,0.3924579124579125,-1.015144369536748,0.9305446843393769,0.9996715223698593,0.8496233601428045,ITPKC,1
Metabolism,Global and overview maps,hsa01232,Nucleotide metabolism,1/225,34/2914,0.029411764705882353,0.38091503267973853,-1.0501699171496395,0.9359689974333165,0.9996715223698593,0.8496233601428045,PNP,1
Organismal Systems,Sensory system,hsa04742,Taste transduction,1/225,35/2914,0.02857142857142857,0.370031746031746,-1.0844210883702268,0.9409714195088388,0.9996715223698593,0.8496233601428045,GABRA6,1
Human Diseases,Neurodegenerative disease,hsa05022,Pathways of neurodegeneration - multiple diseases,8/225,163/2914,0.049079754601226995,0.6356373551465576,-1.3846769192926287,0.9455162947744402,0.9996715223698593,0.8496233601428045,NDUFS1/WNT8A/TNFRSF1A/IL1B/IL6/TUBB6/WNT7B/CASP12,8
Human Diseases,Infectious disease: bacterial,hsa05100,Bacterial invasion of epithelial cells,1/225,36/2914,0.027777777777777776,0.35975308641975307,-1.1179424554015895,0.9455846291686203,0.9996715223698593,0.8496233601428045,ITGA5,1
Human Diseases,Neurodegenerative disease,hsa05014,Amyotrophic lateral sclerosis,4/225,96/2914,0.041666666666666664,0.5396296296296296,-1.3265957049551518,0.9471517302800665,0.9996715223698593,0.8496233601428045,NDUFS1/TNFRSF1A/TUBB6/CASP12,4
Human Diseases,Neurodegenerative disease,hsa05016,Huntington disease,4/225,96/2914,0.041666666666666664,0.5396296296296296,-1.3265957049551518,0.9471517302800665,0.9996715223698593,0.8496233601428045,NDUFS1/CREB3L1/TUBB6/TGM2,4
Metabolism,Nucleotide metabolism,hsa00230,Purine metabolism,2/225,59/2914,0.03389830508474576,0.43902071563088513,-1.2590294066724594,0.9497917894393197,0.9996715223698593,0.8496233601428045,ALLC/PNP,2
Organismal Systems,Endocrine system,hsa04929,GnRH secretion,1/225,37/2914,0.02702702702702703,0.35003003003003,-1.150774747228516,0.9498387842892111,0.9996715223698593,0.8496233601428045,SPP1,1
Cellular Processes,Cellular community - eukaryotes,hsa04530,Tight junction,2/225,60/2914,0.03333333333333333,0.43170370370370365,-1.2864400928686275,0.9530794744425499,0.9996715223698593,0.8496233601428045,YBX3/RUNX1,2
Metabolism,Global and overview maps,hsa01200,Carbon metabolism,1/225,38/2914,0.02631578947368421,0.34081871345029235,-1.1829552810576303,0.9537617156534544,0.9996715223698593,0.8496233601428045,HK2,1
Organismal Systems,Endocrine system,hsa04935,"Growth hormone synthesis, secretion and action",2/225,61/2914,0.03278688524590164,0.4246265938069217,-1.313499515192221,0.9561616425242783,0.9996715223698593,0.8496233601428045,CREB3L1/SOCS3,2
Cellular Processes,Transport and catabolism,hsa04142,Lysosome,1/225,39/2914,0.02564102564102564,0.3320797720797721,-1.214518334933429,0.9573791057709692,0.9996715223698593,0.8496233601428045,SLC11A1,1
Environmental Information Processing,Signal transduction,hsa04152,AMPK signaling pathway,1/225,39/2914,0.02564102564102564,0.3320797720797721,-1.214518334933429,0.9573791057709692,0.9996715223698593,0.8496233601428045,CREB3L1,1
Organismal Systems,Endocrine system,hsa04918,Thyroid hormone synthesis,1/225,39/2914,0.02564102564102564,0.3320797720797721,-1.214518334933429,0.9573791057709692,0.9996715223698593,0.8496233601428045,CREB3L1,1
Organismal Systems,Aging,hsa04211,Longevity regulating pathway,1/225,40/2914,0.025,0.32377777777777783,-1.2454954708763193,0.9607146540149802,0.9996715223698593,0.8496233601428045,CREB3L1,1
Organismal Systems,Digestive system,hsa04976,Bile secretion,1/225,40/2914,0.025,0.32377777777777783,-1.2454954708763193,0.9607146540149802,0.9996715223698593,0.8496233601428045,SLC4A5,1
Cellular Processes,Cellular community - eukaryotes,hsa04540,Gap junction,1/225,43/2914,0.023255813953488372,0.30118863049095607,-1.3351919154698577,0.9692406157545057,0.9996715223698593,0.8496233601428045,TUBB6,1
Human Diseases,Cancer: overview,hsa05231,Choline metabolism in cancer,1/225,43/2914,0.023255813953488372,0.30118863049095607,-1.3351919154698577,0.9692406157545057,0.9996715223698593,0.8496233601428045,RAC2,1
Organismal Systems,Endocrine system,hsa04912,GnRH signaling pathway,1/225,46/2914,0.021739130434782608,0.28154589371980676,-1.4205432927666017,0.9759226344233409,0.9996715223698593,0.8496233601428045,EGR1,1
Organismal Systems,Nervous system,hsa04723,Retrograde endocannabinoid signaling,2/225,70/2914,0.02857142857142857,0.370031746031746,-1.5430108816397528,0.9764348137001195,0.9996715223698593,0.8496233601428045,NDUFS1/GABRA6,2
Organismal Systems,Digestive system,hsa04970,Salivary secretion,1/225,47/2914,0.02127659574468085,0.27555555555555555,-1.448125726609468,0.9778115490867817,0.9996715223698593,0.8496233601428045,LYZ,1
Organismal Systems,Sensory system,hsa04740,Olfactory transduction,1/225,49/2914,0.02040816326530612,0.2643083900226757,-1.5020957951199974,0.9811581163139592,0.9996715223698593,0.8496233601428045,OR2AT4,1
Organismal Systems,Circulatory system,hsa04261,Adrenergic signaling in cardiomyocytes,2/225,74/2914,0.02702702702702703,0.35003003003003,-1.6380082388907236,0.9822023905375306,0.9996715223698593,0.8496233601428045,CREB3L1/PLN,2
Organismal Systems,Endocrine system,hsa04911,Insulin secretion,1/225,51/2914,0.0196078431372549,0.2539433551198257,-1.5545772832009301,0.9840018414834573,0.9996715223698593,0.8496233601428045,CREB3L1,1
Organismal Systems,Nervous system,hsa04722,Neurotrophin signaling pathway,1/225,52/2914,0.019230769230769232,0.24905982905982907,-1.5802954677013061,0.9852591190476285,0.9996715223698593,0.8496233601428045,NGFR,1
Human Diseases,Substance dependence,hsa05032,Morphine addiction,1/225,53/2914,0.018867924528301886,0.24436058700209645,-1.6056826257833288,0.986417993336337,0.9996715223698593,0.8496233601428045,GABRA6,1
Organismal Systems,Endocrine system,hsa04921,Oxytocin signaling pathway,2/225,81/2914,0.024691358024691357,0.3197805212620027,-1.7957024973967035,0.9891781089077794,0.9996715223698593,0.8496233601428045,CDKN1A/NOS3,2
NA,NA,hsa04082,Neuroactive ligand signaling,4/225,124/2914,0.03225806451612903,0.4177777777777778,-1.9163005257307049,0.9896267705333011,0.9996715223698593,0.8496233601428045,GABRA6/P2RY12/P2RY6/P2RY13,4
Human Diseases,Substance dependence,hsa05034,Alcoholism,2/225,86/2914,0.023255813953488372,0.30118863049095607,-1.902547838022208,0.9924482097405211,0.9996715223698593,0.8496233601428045,FOSB/CREB3L1,2
Organismal Systems,Nervous system,hsa04726,Serotonergic synapse,1/225,64/2914,0.015625,0.2023611111111111,-1.8661217603435936,0.994492525288149,0.9996715223698593,0.8496233601428045,ALOX12B,1
Organismal Systems,Nervous system,hsa04725,Cholinergic synapse,1/225,67/2914,0.014925373134328358,0.19330016583747925,-1.9320650111535214,0.9956970465629094,0.9996715223698593,0.8496233601428045,CREB3L1,1
Organismal Systems,Nervous system,hsa04728,Dopaminergic synapse,1/225,69/2914,0.014492753623188406,0.18769726247987117,-1.9750014877029225,0.9963504107227458,0.9996715223698593,0.8496233601428045,CREB3L1,1
Metabolism,Global and overview maps,hsa01100,Metabolic pathways,24/225,537/2914,0.0446927374301676,0.578820608317815,-3.1254011328805524,0.9996715223698593,0.9996715223698593,0.8496233601428045,NDUFS1/MTHFD2/DHRS9/ITPKC/SI/PYGL/IL4I1/NAMPT/VNN2/PRDM7/PLA2G5/CHSY1/BCO1/GALNT5/ALLC/PLOD2/HK2/HPGDS/NOS3/PLD4/ALOX12B/ACSL5/PNP/ACY1,24
